Variability of blood pressure in dialysis patients: A new marker of cardiovascular risk?

Journal of Nephrology

Volumn 26, Issue 1, 2013, Pages 173-182

  Di Iorio, Biagio ^a   Di Micco, Lucia ^a   Torraca, Serena ^a   Sirico, Maria Luisa ^a   Guastaferro, Pasquale ^b   Chiuchiolo, Luigi ^c   Nigro, Filippo ^b   De Blasio, Antonietta ^b   Romano, Paolo ^b   Pota, Andrea ^a   Rubino, Roberto ^d   Morrone, Luigi ^e   Lopez, Teodoro ^f   Casino, Francesco Gaetano ^f  

^a A Landolfi Hospital   (Italy)

^b Division of Nephrology   (Italy)

^c 'Dialysis'   (Italy)

^d Ariano Irpino Hospital ASL AV1   (Italy)

^e G RUMMO HOSPITAL   (Italy)

^f Province of Matera   (Italy)

Author keywords

Blood pressure variability; Dialysis; Mortality

Indexed keywords

ALBUMIN; CREATININE;

ADULT; ARTICLE; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART DEATH; HEMODIALYSIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PULSE PRESSURE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CONFIDENCE INTERVALS; CREATININE; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RENAL DIALYSIS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; YOUNG ADULT;

EID: 84866275248     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000108     Document Type: Article

References (31)

1. Kannel WB. Role of blood pressure in cardiovascular disease: the Framingham Study. Angiology. 1975;26(1 Pt. 1):1-14.
2. Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375(9718): 895-905.
3. Schillaci G, Pucci G. The importance of instability and visitto-visit variability of blood pressure. Expert Rev Cardiovasc Ther. 2010;8(8):1095-1097.
4. Hansen TW, Thijs L, Li Y, et al; International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension. 2010;55(4):1049-1057.
5. Kai H, Kudo H, Takayama N, Yasuoka S, Kajimoto H, Imaizumi T. Large blood pressure variability and hypertensive cardiac remodeling-role of cardiac inflammation. Circ J. 2009;73(12):2198-2203.
6. Kikuya M, Ohkubo T, Metoki H, et al. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study. Hypertension. 2008;52(6):1045-1050.
7. Rohrscheib MR, Myers OB, Servilla KS, et al; DCI Medical Directors. Age-related blood pressure patterns and blood pressure variability among hemodialysis patients. Clin J Am Soc Nephrol. 2008;3(5):1407-1414.
8. Murashima M, Kumar D, Doyle AM, Glickman JD. Comparison of intradialytic blood pressure variability between conventional thrice-weekly hemodialysis and short daily hemodialysis. Hemodial Int. 2010;14(3):270-277.
9. Mitsuhashi H, Tamura K, Yamauchi J, et al. Effect of losartan on ambulatory short-term blood pressure variability and cardiovascular remodeling in hypertensive patients on hemodialysis. Atherosclerosis. 2009;207(1):186-190.
10. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217-223.
11. Turnbull F; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet. 2003;362(9395):1527-1535.
12. Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289(18):2363-2369.
13. De Nicola L, Chiodini P, Zoccali C, et al; SIN-TABLE CKD Study Group. Prognosis of CKD patients receiving outpatient nephrology care in Italy. Clin J Am Soc Nephrol. 2011;6(10):2421-2428.
14. De Nicola L, Minutolo R, Chiodini P, et al; TArget Blood Pressure LEvels in Chronic Kidney Disease (TABLE in CKD) Study Group. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int. 2006;69(3):538-545.
15. De Nicola L, Minutolo R, Zamboli P, et al; Investigators of TArget Blood Pressure LEvels in Chronic Kidney Disease (TABLE in CKD) Study Group. Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study. Semin Nephrol. 2003;25(6):425-430.
16. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2005;42(6):1206-1252.
17. Mancia G, De Backer G, Dominiczak A, et al; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25(6):1105-1187.
18. O'Brien E, Asmar R, Beilin L, et al; European Society of Hypertension Working Group on Blood Pressure Monitoring. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005;23(4):697-701.
19. Rothwell PM, Howard SC, Dolan E, et al; on behalf of the ASCOT-BPLA and MRC Trial Investigators. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9(5):469-480.
20. Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet. 2010;375(9718):938-948.
21. Webb AJ. Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and metaanalysis. Lancet. 2010;375:906-915.
22. Agarwal R, Weir MR. Dry weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients. Clin J Am Soc Nephrol. 2010;5(7):1255-1260.
23. De Nicola L, Minutolo R, Bellizzi V, et al; investigators of the TArget Blood Pressure LEvels in Chronic Kidney Disease (TABLE in CKD) Study Group. Achievement of target blood pressure levels in chronic kidney disease: a salty question? Am J Kidney Dis. 2004;43(5):782-795.
24. Kim KI, Lee JH, Chang HJ, et al. Association between blood pressure variability and inflammatory marker in hypertensive patients. Circ J. 2008;72(2):293-298.
25. Lee HT, Lim YH, Kim BK, et al. The relationship between ambulatory arterial stiffness index and blood pressure variability in hypertensive patients. Korean Circ J. 2011;41(5):235-240.
26. Schutte AE, Schutte R, Huisman HW, et al. Blood pressure variability is significantly associated with ECG left ventricular mass in normotensive Africans: the SABPA Study. Hypertens Res. 2011;34(10):1127-1134.
27. Gupta AK, Cornelissen G, Greenway FL, et al. Abnormalities in circadian blood pressure variability and endothelial function: pragmatic markers of adverse cardiovascular function in asymptomatic obese adult. Cardiovasc Diabetol. 2010;9:58-70.
28. Gentile G, Strippoli GF. Should we shift toward higher blood pressure targets in patients with chronic kidney disease? J Nephrol. 2011;24(6):673-685.
29. Culleton BF, Asola MR. The impact of short daily and nocturnal hemodialysis on quality of life, cardiovascular risk and survival. J Nephrol. 2011;24(4):405-415.
30. Di Micco L, Torraca S, Sirico ML, et al. Daily dialysis reduces pulse wave velocity in chronic haemodialysis patients. Hypertens Res. 2012 Jan 26. [Epub ahead of print]
31. Heerspink HJL, Ninomiya T, Zoungas S, et al. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet. 2009;373(9668):1009-1015.